CXCL12 and myocardial infarction: We found that SDF‐1‐AnxA5 improved left ventricular ejection fractions after MI by 69% (SDF‐1‐AnxA5 group vs control, 40.2% ± 5.2% vs 23.8% ± 3.2%, P < .05, Figure 5C).